Letter to the Editor
Copyright ©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 107017
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.107017
Table 1 Main molecular targets and mechanisms of action of curcumol
Molecular target
Normal function
Changes in DR
Regulatory effect of curcumol
Downstream pathological impact
Ref.
FTO proteinm6A demethylase; regulates RNA stability and expressionAbnormal expression under high-glucose conditions; significantly elevated in fibrovascular vitreous membranes of proliferative DR patientsIncreases FTO expression, activating its demethylase activityStabilizes MAFG-AS1 expression, inhibits endothelial inflammation and vascular leakageRong et al[1]
MAFG-AS1Long non-coding RNA involved in metabolism and inflammation regulationIncreased m6A modification and decreased stability under high-glucose conditionsStabilizes MAFG-AS1 through FTO-mediated demethylationSuppresses high glucose-induced endothelial proliferation, migration, and inflammationRong et al[1]
Histone lactylationEpigenetic modification regulating gene expressionLactate-mediated histone lactylation upregulates FTO expressionPossibly indirectly regulates FTO expression via modulation of histone lactylationForms a more complex epigenetic regulatory network, influencing retinal vascular integrityChen et al[6]
Inflammatory cytokinesMediate immune responses and tissue repairElevated pro-inflammatory cytokines (TNF-α, IL-6), triggering chronic inflammationDownregulates IκBα, cyclooxygenase-2, prostaglandin E2, and multiple interleukinsReduces retinal inflammation, protecting retinal neurons and vascular functionFranzone et al[50]
Blood-retinal barrier componentsMaintain homeostasis in the retinal microenvironmentReduced cadherin and tight junction protein ZO-1 expression, impairing barrier functionRestores endothelial-specific cadherin and ZO-1 expressionReduces vascular leakage, protecting retinal neurons from damageChen et al[6]